Roles of immunoglobulin-like loops of junctional cell adhesion molecule 4; involvement in the subcellular localization and the cell adhesion
✍ Scribed by Makiko Tajima; Susumu Hirabayashi; Ikuko Yao; Madoka Shirasawa; Junichi Osuga; Shun Ishibashi; Toshiro Fujita; Yutaka Hata
- Book ID
- 104460512
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 361 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1356-9597
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background: Membrane‐associated guanylate kinase with inverted domain structure‐1 (MAGI‐1) is a scaffolding protein at tight junctions (TJs). We have recently identified junctional adhesion molecule 4 (JAM4) as a MAGI‐1‐interacting protein. JAM4 belongs to the immunoglobulin superfamily and mediates Ca^2+^‐independent adhesion. In this study, we examined the subcellular localization of JAM4 in various tissues and the involvement of JAM4 in the localization of MAGI‐1. Moreover, we investigated into roles of immunoglobulin‐like loops (Ig‐loops) of JAM4.
Results: JAM4 was localized at TJs but also on apical membranes of epithelial cells in jejunum, ileum, and renal proximal tubules. In Madine Darby canine kidney (MDCK) cells, the localization of JAM4 at TJs depended on the first Ig‐loop and did not require the MAGI‐1‐interacting region. JAM4 determined the subcellular localization of MAGI‐1 in MDCK cells. In ileum, however, MAGI‐1 was localized at TJs where JAM4 was not detected. Both of Ig‐loops were necessary for homophilic interactions, but cis interactions depended on the first Ig‐loop.
Conclusion: JAM4 may be primarily targeted to apical membranes, and subsequently recruited to TJs through the first Ig‐loop–mediated molecular interaction. JAM4 determines the localization of MAGI‐1 in MDCK cells, but the in vivo localization of MAGI‐1 does not necessarily depend on JAM4.
📜 SIMILAR VOLUMES
## Abstract Subsequent to our identification of a novel immunoglobulin‐like cell adhesion molecule hepaCAM, we showed that hepaCAM is frequently lost in diverse human cancers and is capable of modulating cell motility and growth when re‐expressed. Very recently, a molecule identical to hepaCAM (des